黑龙江地区HIV合并HCV感染人群流行病学特征及死亡因素分析
DOI:
作者:
作者单位:

作者简介:

杨君微,硕士研究生,主治医师,主要研究方向:医院传染性疾病控制

通讯作者:

中图分类号:

R181

基金项目:


Epidemic characteristics and factors influencing mortality in HIV/HCV co-infected population in Heilongjiang Region
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探究黑龙江地区人类免疫缺陷病毒(human immunodeficiency virus , HIV)合并丙型肝炎病毒(hepatitis C virus , HCV)感染人群流行病学特征及死亡影响因素。方法 回顾性分析2019年1月-2023年12月于北大荒集团总医院就诊的712例HIV感染患者的临床资料,采用ELISA检测其HCV感染情况,分析HIV合并HCV感染人群流行特征;根据随访的结果将116例双重感染的患者分为存活组(n=90)和死亡组(n=26),分析HIV合并HCV双重感染患者死亡的危险因素。结果 HIV合并HCV感染率为16.29%,30~50岁年龄段人群合并感染率(25.47%)最高,职业为农民的合并感染率(26.85%)最高,以静脉吸毒途径感染的合并感染率最高(61.90%)。多因素Logistic回归结果显示,HIV 感染确诊年龄(OR=1.827,95%CI:1.263~2.722)、感染途径(OR=1.796,95%CI:1.248~2.503)、抗病毒治疗(OR=1.724,95%CI:1.202~2.367)、首次CD4+T淋巴细胞(OR=2.536,95%CI:1.776~3.739)、确诊至启动治疗时间间隔(OR=1.953,95%CI:1.431~2.952)是合并感染患者死亡的危险因素(P<0.05)。结论 HIV合并HCV感染率为16.29%,合并感染率较高。为降低双重感染死亡率应重点关注≥40岁、静脉吸毒、未抗病毒治疗、首次CD4+T淋巴细胞水平较低、确诊至启动治疗时间间隔较长的患者,临床积极治疗改善免疫功能,延长患者生命。

    Abstract:

    Objective To investigate the epidemic characteristics and factors influencing mortality in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected patients in heilongjiang region. Methods The clinical data of 712 HIV-infected patients attending our hospital from January 2019 to December 2023 were analyzed retrospectively. The HCV infections were detected by ELISA, and epidemic characteristics of HIV/HCV co-infected patients were analyzed . Co-infected patients (n=116) were classified into survival group (n=90) and death group (n=26) according to the follow-up results, and risk factors for the mortality of HIV/HCV co-infected patients were identified. Results The prevalence of HIV/HCV co-infection was 16.29%, and the prevalence was the highest in 30-50 age group, accounting for 25.47%. There was no significant difference in co-infection rates by gender and marital status (P>0.05). The co-infection rate was the highest among farmers (26.85%) by occupation and among intravenous drug users (61.90%) by route of infection. No statistical difference was found in gender, marital status, and occupational status between survival group and death group (P>0.05), whereas statistical difference was found in age at diagnosis of HIV infection, route of infection, antiretroviral treatment, percentage of CD4+T lymphocytes, and interval between diagnosis and initiation of treatment between two groups (P<0.05). Multivariate Logistic regression analysis denoted that age at diagnosis of HIV infection (OR=1.827, 95% CI: 1.263-2.722), route of infection (OR=1.796, 95% CI: 1.248-2.503), antiretroviral treatment (OR=1.724, 95% CI: 1.202-2.367), percentage of CD4+T lymphocytes (OR=2.536, 95% CI: 1.776-3.739), and the time interval between diagnosis and initiation of treatment (OR=1.953, 95% CI: 1.431-2.952) were all associated with the risk of mortality in co-infected patients (P<0.05). Conclusion The overall prevalence of HIV/HCV co-infection is 16.29% in heilongjiang region . In order to reduce the mortality rate of superinfection , we should focus on patients who are ≥ 40 years old, intravenous drug use , no antiviral therapy , low CD4+ T lymphocyte levels for the first time , and have a long interval between diagnosis and initiation of treatment .

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-12-04
  • 最后修改日期:2024-12-04
  • 录用日期:
  • 在线发布日期: 2025-01-15
  • 出版日期:
文章二维码